. Inositol phospholipids localized to caveolae in rat heart are regulated by ␣1-adrenergic receptors and by ischemia-reperfusion. Am J Physiol Heart Circ Physiol 290: H2059 -H2065, 2006. First published December 22, 2005; doi:10.1152/ajpheart.01210.2005.-Postischemic reperfusion of rat or mouse hearts causes generation of inositol (1, 4, 5) trisphosphate [Ins(1, 4, 5 )P3] and the initiation of arrhythmias. In the current study we investigated the possibility that the enhanced Ins(1,4,5)P3 generation in postischemic reperfusion was associated with an increased availability of the precursor lipid phosphatidylinositol(4,5)bisphosphate (PIP2) for ␣1-adrenergic receptor-activated phospholipase C (PLC). Isolated-perfused rat hearts were labeled with [
tection (43) . Further to these roles as precursor to other active molecules, PIP 2 itself acts as a second messenger by activating phospholipase D activity in the heart (25) . PIP 2 is critically important in stabilizing various ion channels and transporters (22, 32) and also regulates the cytoskeleton by virtue of its ability to interact specifically with actin-binding proteins via their plextrin homology (PH) domains (32) . With this complexity in mind, we sought to define the localization of PIP 2 in the heart in relation to signaling proteins involved in Ins(1,4,5)P 3 generation, specifically ␣ 1 -AR, Gq, and PLC␤, and to establish how the localization of these various factors was influenced by ischemia and reperfusion.
The sarcolemma is highly organized, and it is now recognized that many signaling responses are localized to cholesterolrich, sphingolipid-rich regions called light lipid rafts to reflect their low buoyant densities (20, 37) . Important among this heterogeneous fraction are the caveolae, which in the heart are characterized by the presence of caveolin-3 (47) . The concentration of receptors and downstream factors within caveolae facilitates regulation and potentially enhances specificity by physically limiting available signaling partners (20, 28, 37) . In the heart, the caveolar fraction has been reported to contain ␣ 1 -AR, Gq, and the subtypes of PLC␤ (15) , but the localization of PIP 2 and its precursors have not been defined.
In the current study, we show that PIP 2 , as well as its precursors PIP and PI, is highly enriched in the caveolar fraction along with the lower molecular weight "b" splice variant of PLC␤1 (4) . Other proteins potentially involved in ␣ 1 -AR signaling were not exclusively localized in caveolae, suggesting a previously unrecognized level of specificity for PLC␤1b. We show that caveolar-localized PIP 2 is rapidly depleted by ␣ 1 -AR activation, but surprisingly that brief ischemia followed by reperfusion increases the content of PIP 2 in caveolae independently of norepinephrine release and ␣ 1 -AR activation. This rise in PIP 2 in the vicinity of PLC␤1b may contribute to the enhanced Ins(1,4,5)P 3 generation observed under these conditions.
METHODS
Preparation of perfused rat hearts, ischemia-reperfusion, and norepinephrine depletion. All procedures were approved by the Alfred Medical and Education Precinct animal ethics committee and all followed the guidelines of the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Adult male SpragueDawley rats were killed by decapitation. Hearts were isolated and perfused by the Langendorf method with HEPES-buffered Krebs medium, pH 7.4, at 7 ml/min, as previously described in detail (1) . The medium contained the following (in mM): 126 NaCl, 25 NaHCO 3, 1.85 CaCl2, 1.05 MgCl2, 0.5 NaH2PO4, 4 KCl, 11 glucose, and 20 HEPES buffer, pH 7.4. Inositol phospholipids were labeled by perfusing the hearts with medium containing 2 Ci/ml [ 3 H]inositol for 2 h, at 7 ml/min, followed by washing with nonradioactive medium. LiCl (10 mM) and propranolol (1 M) were then added to the perfusate to inhibit inositol phosphate metabolism and ␤-adrenergic receptor activation, respectively (1) .
For studies of ischemia and reperfusion, [ 3 H]inositol-labeled hearts were subjected to 20 min global zero-flow ischemia by turning off the perfusion pump for 20 min. Reperfusion was initiated by restarting flow at 7 ml/min. For studies of norepinephrine, stimulation under normoxic conditions norepinephrine (100 M) was added to [ 3 H]-inositol-labeled hearts for 2 min. After treatment, ventricles were excised at the atrioventricular junction and were rapidly frozen in liquid N 2 and stored at Ϫ80°C. Protocols are outlined in Fig. 1 .
Depletion of norepinephrine was achieved by treating the animals with reserpine (5 mg/kg body wt ip) for 18 h. This reduced norepinephrine levels in the hearts from 24.4 Ϯ 10.4 pmol/mg protein (means Ϯ SE, n ϭ 4) to undetectable levels. Norepinephrine was measured as described previously (14) .
Separation of different membrane fractions from isolated perfused rat hearts. All solutions for preparation of membrane fractions contained the following proteinase and phosphatase inhibitors: 10 g/ml leupeptin, 5 g/ml aprotinin, 1 g/ml pepstatin, 1 mM phenylmethylsulfonylfluoride, 1 mM dithiothreitol, 20 mM NaF, 1 mM Na 3VO4, and 1 mM sodium pyrophosphate. Frozen hearts were homogenized in 2.5 ml of 0.5 M NaCO 3, pH 11, by using a Polytron homogenizer at maximum speed. Homogenates were sonicated three times for 20 s each and then mixed with an equal volume of 80% sucrose in MES-buffered saline (25 mM MES, pH 6.5, 0.15 M NaCl), as described elsewhere (39) . Tubes were overlayed with 4 ml of 35% sucrose and 3 ml of 5% sucrose and centrifuged at 38,000 rpm for 24 h at 4°C using a SW-41 rotor in a Beckman L-90K ultracentrifuge. Gradients were fractionated from the bottom using a peristaltic pump. Fractions (1 or 2 ml) were collected. The same fractions were used for lipid analysis and for estimation of protein content. The fractions were divided into two equal aliquots, one being used for lipid extractions, as described below. The other aliquot was used for measurement of membrane protein content. These aliquots were diluted to 10 ml with MES-buffered saline, and membranes were separated from soluble material by centrifugation in a 70.1 Ti rotor at 50,000 rpm for 30 min. Membrane pellets were used for protein analysis and ␣ 1-AR quantification, as outlined below.
Measurement of [ 3 H]inositol phospholipids.
Phospholipids were extracted from the fractions using an equal volume of CHCl3/CH3OH/ HCl (200/100/1 vol/vol/vol). Phases were separated by adding 2 mM EDTA, and the lipid phase was evaporated under vacuum. Dried lipids were deacylated using methylamine/CH 3OH/butanol (42/47/9 vol/vol/vol) for 45 min at 50°C, followed by evaporation. Dried deacylated lipids were extracted with petroleum spirit-butanol-ethyl formate, as described previously (49) . The deacylated lipids were separated into PI, PIP, and PIP 2 fractions using 1-ml columns of Dowex-1 (formate form), as described previously (49 (53) . Membranes, prepared as described above (100 l), were mixed with 50 l of [ 125 I]HEAT (50 -100 pM, 50,000 -100,000 counts/min) and 50 l of KMD-3213 (10 Ϫ11 to 10 Ϫ5 M) in 20 mM Tris ⅐ HCl, 10 mM MgCl2, pH 7.4, for 60 min at 25°C. Bound ligand was separated from unbound by rapid filtration through Whatman GF/C glass fiber filters under vacuum, followed by rapid washing with 20 ml of the above buffer. Filters were counted in a gamma counter. Binding data were analyzed using Prism 4.0 (GraphPad Software, San Diego, CA) to provide best-fit estimates for receptor concentration and affinity for both receptor subtypes (26) .
Measurement of membrane proteins. Pelleted membranes, prepared as described above, were solubilized in SDS-PAGE sample buffer (8) . Protein concentration was measured by a modified Lowry estimation (33) . Proteins (100 g) were separated on gradient SDS-PAGE (7.5-15% acrylamide) and electrophoretically transferred to nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany). Membranes were stained with Ponceau S (Sigma) before blocking and subsequent development with antibodies. The antibodies used were the following: G␣q/11 (1/250, COOH-terminal directed, Santa Cruz), PLC␤1 (1 g/ml, Santa Cruz), and PLC␤3 (1 g/ml, Santa Cruz). Secondary antibodies were from Amersham Life Sciences, and bound antibody was detected using chemiluminescence-employing ECL reagents from Amersham Life Sciences (Bucks, UK). Band density was quantified from scanned images using Optimas 6.5 software (Media Cybernetics, Silver Spring, MD).
Statistical analysis. Comparisons between two groups were made using Student's unpaired t-test. Where comparisons involved more than two groups, data analysis was performed using a two-way ANOVA followed by Tukey's test. Analyses were performed using Sigma Stat 2.03 for Windows (Systat Software, Point Richmond, CA).
RESULTS

Reperfusion of ischemic rat hearts increases PIP 2 independently of norepinephrine release. Isolated perfused [
3 H]inositol-labeled rat hearts were subjected to 20 min global zero-flow ischemia followed by reperfusion for 0.5-3 min and then snap frozen (1 (Fig. 2) .
To ensure that the rise in PIP 2 in norepinephrine-depleted hearts reflected a loss of PLC activity, a number of experiments were performed. First, 100 M norepinephrine was added to the perfusate of the norepinephrine-depleted hearts during 2 min of reperfusion, resulting in the generation of Ins(1,4,5)P 3 with no increase in PIP 2 (Fig. 3) . Second, 1.5 mM gentamicin was added during reperfusion of intact hearts (not reserpine treated) to inhibit PLC (24) . Treatment with gentamicin prevented Ins(1,4,5)P 3 generation, as reported previously (13), and also resulted in increased PIP 2 (Fig. 3) . Thus the ischemia-reperfusion procedure generates PIP 2 independently of norepinephrine release. When PLC is activated by ␣ 1 -adrenergic receptor activation, this PIP 2 increase is not observed, implying that the increased PIP 2 provides a substrate for the activated PLC.
PIP 2 is concentrated in caveolar fractions of rat heart membranes, along with G␣q and PLC␤1. The localization of the PIP 2 in cardiac sarcolemma was investigated to establish whether the PIP 2 that increased during reperfusion was likely to be available for receptor-activated PLC hydrolysis to Ins(1,4,5)P 3 . Previous studies have reported that proteins required for ␣ 1 -AR signaling are localized to the caveolar fractions isolated from rat hearts (12, 15) . However, these studies did not define the localization of PI, PIP, and PIP 2 . To examine the localization of these lipids in rat heart membranes, perfused [ (Fig. 4) . Membranebound PLC␤1 was almost exclusively found in the caveolar fractions (Fig. 4, Table 1 ). In the adult rat heart, we observed only the lower molecular mass splice variant of PLC␤1, PLC␤1b (140 kDa mol mass). The two splice variants of PLC␤1, PLC␤1a, and PLC␤1b (150 and 140 kDa mol mass, respectively) described in other cells types (4) are detectable in neonatal rat cardiomyocytes but not in caveolae from adult rat heart (Fig. 4) . G␣q was found in the caveolar fraction as well as in higher density membranes, although relative to protein content G␣q was highly enriched in the caveolae fraction (Fig. 4, Table 1 ). In marked contrast to PLC␤1b, membrane fractions contained relatively little PLC␤3 (only 1-5% of the total cellular content of PLC␤3), and this was not highly enriched in caveolae (Fig. 4) . Other proteins found in the caveolar fractions included PLC␦1, epidermal growth factor receptors, and PI(4)P 5-kinase1␣. PI(4)P 5-kinase1␤ was not detected in rat hearts (data not shown).
␣ 1 -AR are not concentrated in caveolae in rat hearts. The caveolar localization of ␣ 1A -and ␣ 1B -AR was then assessed. Overall rat heart membranes contained 745.1 Ϯ 161.8 fmol/ heart of ␣ 1 -AR, and of these, 79.3 Ϯ 7.3% were the ␣ 1B -subtype (means Ϯ SE, n ϭ 6). However, only 27.3 Ϯ 6.9% of the total ␣ 1 -AR complement was found in the caveolar fractions (Fig. 5 (Fig. 4, Table 1 ). There was no difference between the ␣ 1A -and ␣ 1B -subtypes in terms of localization (Fig. 5) . The small percentage of ␣ 1 -AR located in the caveolar Fig. 4 [ 3 H]Inositol-labeled rat hearts were subjected to 20 min ischemia followed by 2 min ischemia-reperfusion (I/R) or to 2 min stimulation with 100 M norepinephrine (Nor) in normoxia. Membrane fractions of different buoyant densities were separated. Content of the ␣1-adrenergic receptor (AR), G␣q, and PLC␤1 were measured in the caveolar fractions (9 -12 ml from the bottom of gradient) and in noncaveolar fractions (1-8 ml) . Values shown are the total content of the protein in caveolae expressed as a percentage of total membrane content (not the total cellular content). Values shown are % in caveolae, means Ϯ SE; n values are indicated in parenthesis. *P Ͻ 0.05 relative to 20 min ischemia. fraction along with its substrate PIP 2 and its immediate signaling proteins G␣q and PLC␤1 suggested that localization may limit the activity of ␣ 1 -AR signaling.
We next examined whether norepinephrine stimulation under normoxic conditions or postischemic reperfusion caused movement of ␣ 1 -AR into caveolae or alternatively moved G␣q or PLC␤1 to membranes of higher density where most of the ␣ 1 -AR are located. [ 3 H]inositol-labeled rat hearts were subjected to ischemia-reperfusion, and membrane fractions were separated on the basis of their buoyant densities. ␣ 1 -AR (ligand binding), PLC␤1, and G␣q (Western blots) were measured in the same membrane fractions as used for inositol phospholipid quantifications (shown below). Western blots were quantified, and the percentage of the particular protein in the caveolar fractions was estimated relative to the content of all membrane fractions added together. As shown in Table 1 , stimulation with 100 M norepinephrine for 2 min in normoxia did not cause any detectable change in the distribution of any of these proteins. Reperfusion for 2 min after 20 min ischemia, however, caused a selective loss of ␣ 1 -AR from the caveolar fraction. Loss of ␣ 1 -AR from caveolae, rather than providing an explanation for the heightened response in reperfusion, most likely reflects receptor desensitization (45) .
Ischemia-reperfusion increases PIP 2 in caveolar fractions. The localization of the [
3 H]PIP 2 that increases during postischemic reperfusion was then assessed. [ 3 H]inositol-labeled hearts were subjected to 20 min ischemia, followed by 2 min reperfusion, and membrane fractions were prepared as described above. Neither 20 min ischemia nor 2 min postischemic reperfusion caused any change in the caveolar content of PIP 2 in norepinephrine replete hearts (Fig. 6B) . However, when catecholamine-depleted hearts were used, [ 3 H]PIP 2 increased in the caveolar fractions over the 2-min period of reperfusion (Fig. 6A) (Fig. 6C) . Thus our data suggest that postischemic reperfusion increases the generation of PIP 2 in caveolae independently of norepinephrine release and ␣ 1 -AR activation. This increase in PIP 2 in caveolae, where G␣q and PLC␤1 are concentrated, potentially provides substrate for activated PLC, thereby reducing the caveolar PIP 2 content by generating Ins(1,4,5)P 3 .
DISCUSSION
Reperfusion of ischemic rat or mouse hearts causes norepinephrine release from the cardiac sympathetic nerves (40) , activation of ␣ 1 -AR (42), and consequent generation of Ins(1,4,5)P 3 by PLC hydrolysis of PIP 2 (1). The rise in Ins(1,4,5)P 3 is associated with the onset of arrhythmias that can be prevented by inhibiting PLC activity (13, 24) or by depleting the hearts of norepinephrine. ␣ 1 -AR-mediated Ins(1,4,5)P 3 generation is markedly enhanced over the first 3 min after initiation of reperfusion compared with responses in normoxic myocardium, and we sought to define the mechanisms responsible. Ins(1,4,5)P 3 is generated from the sarcolemmal phospholipid PIP 2 following activation of ␣ 1 -AR, Gq, and PLC␤. In the current study we addressed the possibility that ischemia and reperfusion alter the availability of PIP 2 for PLC␤-mediated hydrolysis to Ins(1,4,5)P 3 .
In heart membranes, we showed that PIP 2 and its precursors PIP and PI are localized in the caveolar fractions along with caveolin-3 (Fig. 4) . Membrane-bound PLC␤1b was also localized exclusively in these fractions (Fig. 4, Table 1 ) where it is well placed to hydrolyze PIP 2 to Ins(1,4,5)P 3 . Rat heart caveolae exhibited only the lower molecular weight "b" splice variant of PLC␤1 (4), in contrast to neonatal rat cardiomyocytes that express both PLC␤1a and PLC␤1b (3) (Fig. 4) . PLC␤1b is important in nuclear responses in some cell types (11) , and the significance of its caveolar localization in the heart is not known. In marked contrast to PLC␤1, the PLC␤3 subtype was largely in the soluble fraction, and the membranebound component was mostly found in noncaveolar membranes essentially devoid of PIP and PIP 2 (Fig. 4) . We have previously reported that ␣ 1 -AR couples exclusively to PLC␤1 in neonatal rat cardiomyocytes, even though these cells express both PLC␤1 and PLC␤3 (3) . At least in some cell types, PLC␤3 can be targeted to particular membrane domains via its COOH-terminal, PDZ-binding domain (7), and it is likely that the different PDZ-binding domains of the PLC␤ subtypes are responsible for their subtype-specific localizations in cardiac membrane fractions (44) . Data shown in Fig. 4 suggest the possibility that ␣ 1 -AR preferentially hydrolyze PIP and PIP 2 via PLC␤1 because of its localization in caveolae along with these lipids. In contrast to the inositol phospholipids and PLC␤1, G␣q was found in both caveolar and nonraft mem- brane fractions, although relative to protein content, it was highly concentrated in the caveolar fractions (Fig. 4, Table 1 ). Thus in the rat heart, most of the factors required for generation of Ins(1,4,5)P 3 are concentrated in caveolae. For this reason it was surprising that ␣ 1 -AR were largely located outside of these fractions (Fig. 5, Table 1 ). This is especially puzzling in light of a recent study showing close association between PIP 2 and PLC-coupled receptors in atrial myocytes (10) . Whereas heavier membrane fractions containing ␣ 1 -AR also contained G␣q, they were essentially devoid of PLC␤1 as well as the lipid substrates PIP and PIP 2 . One possible consequence of this is that the majority of the ␣ 1 -AR population in the heart is unable to activate PLC. If this is so, it may explain the comparatively weak PLC response to ␣ 1 -AR activation in heart preparations compared with other cell types (6, 34, 49 ). Another possibility is that either the ␣ 1 -AR or the lipids translocate with stimulation. Our studies, however, provided no evidence to suggest movement of ␣ 1 -AR into caveolae or movement of PLC␤1 or PIP 2 to membranes of higher density when ␣ 1 -AR were stimulated.
The current studies involve the use of a perfused rat ventricle that contains a number of other cell types in addition to cardiomyocytes. We have previously shown that PLC responses in this model reflect primarily responses in cardiomyocytes (52) . Specifically, we detected no measurable response to angiotensin II or compound 48/80, strong stimuli of vascular smooth muscle and mast cell, respectively. ␣ 1 -AR are not detected on mast cells or cardiac fibroblasts and thus contribution to norepinephrine-dependent responses from these cell types can be discounted. Furthermore, PLC responses in cardiomyocytes differ in terms of rate and in inositol phosphate isomers generated from responses in other cell types (51) .
Having identified caveolae as the site where PIP 2 is hydrolyzed by PLC␤1 to generate inositol phosphates, we next examined how signaling factors in caveolae were influenced by ischemia and reperfusion. Importantly, we found that postischemic reperfusion, but not ischemia itself, caused a selective loss of both ␣ 1 -AR from caveolae (Table 1) , even though Ins(1,4,5)P 3 generation is maximal under these conditions (Fig. 2B) . Rather than contributing to the heightened activity, this loss of ␣ 1 -AR most likely reflects desensitization, although treatment with maximal concentrations of norepinephrine did not cause such changes during normoxia (Table 1) . Such a conclusion is consistent with reports showing movement of ␤ 2 -AR out of caveolae following agonist stimulation of isolated cardiomyocytes (38) .
The current studies show that postischemic reperfusion causes heightened generation of PIP 2 in caveolae independently of norepinephrine release and ␣ 1 -AR activation (Fig. 6 ). This PIP 2 is available for ␣ 1 -AR initiated hydrolysis when stimulated by norepinephrine released under these pathological conditions. Thus the heightened availability of caveolar PIP 2 may contribute to the enhanced generation of Ins(1,4,5)P 3 and thereby to the initiation of arrhythmias under conditions of ischemia and reperfusion. Ins(1,4,5)P 3 causes Ca 2ϩ release from receptors localized on the sarcoplasmic reticulum and the perinuclear membrane (5, 29) . Subsarcolemmal IP 3 receptors on the sarcoplasmic reticulum are clearly present in atrial myocytes (29) , but their expression is undetectably low in ventricle. The possibility remains that ischemia causes an increase in subsarcolemmal IP 3 receptor. The conducting myocytes express a higher concentration of IP 3 receptor (type 1) than working myocytes (46, 19) , and some of these are subsarcolemmal and thus may contribute to arrhythmogenesis. Even though the expression of IP 3 receptor is low in heart, there is evidence that IP 3 receptor activation can perturb the Ca 2ϩ -induced Ca 2ϩ release program orchestrated by the more prevalent ryanodine receptors and lead to increased Na ϩ /Ca 2ϩ exchange (30), a possible mediator of the observed arrhythmias. Furthermore, removal of the type 2 IP 3 receptor, the subtype expressed in working cardiomyocytes (17) , prevented arrhythmogenic responses to PLC activation in mouse atrial myocytes (27) . Importantly, increased IP 3 receptor expression is seen in failed human ventricular tissue (18) and in atrial samples from patients predisposed to atrial fibrillation (54), suggesting a contribution of Ins(1,4,5)P 3 to human pathology. Whereas our studies and those of others have pointed to Ins(1,4,5)P 3 as an initiator of arrhythmias, some recent studies have suggested the possibility of a protective role against postischemic infarction (35, 36, 48) . This may explain our previous finding that the absence of Ins(1,4,5)P 3 generation in mouse hearts expressing constitutively active ␣ 1B -AR reduced arrhythmias but did not limit infarction (16, 21) .
In conclusion, the current studies show that brief periods of ischemia and reperfusion in rat hearts cause a number of changes in the caveolar fraction of rat heart sarcolemma that may be related to enhanced Ins(1,4,5)P 3 generation. Of these, the loss of caveolar ␣ 1 -AR likely reflects heightened receptor activation under these conditions. However, the increased synthesis of PIP 2 in caveolae in early reperfusion may be important as a source of substrate for the generation of the Ins(1,4,5)P 3 when ␣ 1 -AR are activated following release of norepinephrine from the sympathetic nerves.
